Describe bone formation, replacement, repair and calcium homeostasis.

Bone Formation, Repair and Calcium Homeostasis

Clinical Overview

Start with one idea that the rest of the chapter hangs on: the skeleton does two jobs that are constantly in tension. It is the body's structural frame, and it is the body's calcium bank. When those two jobs conflict — when the bloodstream needs calcium that only bone can supply — the bank always wins over the frame, because a falling ionised calcium will stop the heart long before thin bone breaks a hip. Almost everything in O&G bone physiology is a variation on that single trade-off: who is drawing on the calcium bank (a growing fetus, a feeding infant, an overactive parathyroid gland), and what is happening to the frame as a result.

Bone is therefore not inert scaffolding. It is living, vascular, endocrine-responsive tissue that stores calcium and phosphate, provides mechanical support, protects organs, anchors muscle, remodels under load and responds strongly to sex steroids. For O&G, bone matters at four life stages: puberty, when peak bone mass is built; pregnancy, when fetal mineral accretion depends on maternal adaptation; lactation, when calcium is transferred into milk and maternal bone is temporarily mobilised; and menopause, when oestrogen withdrawal accelerates resorption.

The core ideas are:

Bone strength = bone quantity + bone quality. Density is important, but microarchitecture, turnover, mineralisation, collagen quality, microdamage and falls risk also matter.

Calcium homeostasis protects extracellular ionised calcium before it protects the skeleton. If calcium is needed for nerve, muscle, heart and coagulation function, the skeleton becomes the buffer.

Oestrogen restrains osteoclast biology. Loss of oestrogen increases RANKL, reduces OPG, increases inflammatory cytokine tone and accelerates trabecular bone loss.

Pregnancy is not simple calcium depletion. The usual adaptation is increased intestinal calcium absorption, stable ionised calcium and active placental transfer. Lactation relies more on PTHrP-driven skeletal mobilisation, usually followed by recovery after weaning.

Mechanism-to-clinical chain:

Low oestrogen -> increased RANKL/low OPG -> osteoclast survival -> trabecular perforation -> vertebral and distal radius fracture risk.

Third-trimester fetal skeleton -> increased maternal calcitriol and intestinal absorption -> hypercalciuria with stable ionised calcium -> low total calcium may only reflect low albumin.

Lactation -> breast PTHrP plus low ovarian oestrogen -> bone resorption for milk calcium -> transient BMD loss -> recovery after weaning in most women.

Core Knowledge

Bone Cells and Matrix

Bone contains cells embedded in mineralised extracellular matrix. The organic matrix is mainly type I collagen; the inorganic mineral is mainly hydroxyapatite, a calcium-phosphate crystal. The combination gives tensile and compressive strength: collagen resists stretching and bending, while the mineral resists crushing. Think of reinforced concrete — collagen is the steel rebar, hydroxyapatite is the cement. Lose the mineral and the bone bends (osteomalacia); lose the structured collagen and the bone is brittle (as in osteogenesis imperfecta).

A short detour into collagen biochemistry pays off across the whole syllabus, because collagen is the single most abundant protein in the body — type I alone makes up more than half of all body protein. Collagen is built as a triple helix. Fibroblasts and osteoblasts first secrete a soluble precursor, procollagen, which is trimmed extracellularly to tropocollagen, and tropocollagen molecules then assemble into the insoluble fibrils that give tissues their tensile strength. Several collagen genes encode different types for different jobs: type I dominates bone, skin and tendon; type II is the cartilage collagen (and therefore the collagen of the growth plate and the symphysis); type III is the loose, distensible collagen of fetal tissue and early granulation tissue; and type IV forms the basement-membrane sheets under every epithelium. Type III is largely replaced by stronger type I after birth, but it reappears transiently during wound healing — which is exactly why a fresh scar is weaker than the tissue it replaced and why early caesarean or episiotomy wounds must not be overloaded. Vitamin C is an essential cofactor for the hydroxylation step that cross-links collagen, so severe deficiency produces poor wound healing and fragile vessels. This collagen scaffold is the common thread linking bone strength, fracture repair, pelvic ligament behaviour in pregnancy and surgical wound healing.

Osteoblasts arise from mesenchymal lineage cells. They produce osteoid, especially type I collagen, and regulate mineralisation. Some become osteocytes once embedded in matrix. Osteocytes are the mechanosensors: they detect strain, microdamage and disuse, and signal to osteoblasts and osteoclasts. Osteoclasts arise from monocyte/macrophage lineage cells and resorb bone by acidifying the resorption lacuna and digesting matrix.

The master osteoclast pathway is RANK/RANKL/OPG:

Bone modelling changes bone shape and size during growth. Bone remodelling renews existing bone throughout life. Remodelling occurs in basic multicellular units: osteoclasts resorb a packet of bone, then osteoblasts refill it. If formation equals resorption, bone mass is maintained. If resorption exceeds formation, bone mass and architecture deteriorate.